[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337694-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337694-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tumor-agnostic-transcriptome-based-classifier-identifies-spatial-infiltration-patterns-of-cd8t-cells-in-the-tumor-microenvironment-and-predicts-clinical-outcome-in-early-phase-and-late-phase-clinical-trials","Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials","","Immune status in a patient’s tumor microenvironment (TME) can guide cancer immunotherapy and reveal mechanisms of resistance. Existing approaches largely classify CD8+ tumor-infiltrating lymphocytes, yet there is a need for comparable, reliable precision immunophenotyping tools. A study analyzed CD8 immunophenotypes in 2023 patients from 14 phase I–III trials using IHC and RNA-seq. A 92-gene RNA-seq classifier predicted CD8 IHC spatial phenotypes and supported prognostic and predictive associations across cohorts.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tumor-agnostic-transcriptome-based-classifier-identifies-spatial-infiltration-patterns-of-cd8t-cells-in-the-tumor-microenvironment-and-predicts-clinical-outcome-in-early-phase-and-late-phase-clinical-trials/337694/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tumor-agnostic-transcriptome-based-classifier-identifies-spatial-infiltration-patterns-of-cd8t-cells-in-the-tumor-microenvironment-and-predicts-clinical-outcome-in-early-phase-and-late-phase-clinical-trials/337694.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the classifier address in cancer immunotherapy?","Question",{"text":63,"@type":64},"It targets the need for reliable precision immunophenotyping of the tumor microenvironment beyond current CD8+ tumor-infiltrating lymphocyte classification to better guide therapeutic decisions and resistance understanding.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were CD8 immunophenotypes determined in the study?",{"text":68,"@type":64},"CD8 immunophenotypes were classified by pathologists using CD8 immunohistochemistry staining in epithelial and stromal tumor areas, and gene expression was profiled by RNA sequencing.",{"name":70,"@type":61,"acceptedAnswer":71},"What performance and clinical implications are reported for the 92-gene classifier?",{"text":72,"@type":64},"The classifier accurately predicted IHC-based CD8 immunophenotypes in primary and metastatic samples, and it showed prognostic and predictive value in independent patient data, including prolonged overall survival for predicted CD8-inflamed tumors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337694,1790934620,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Open access Original research  \n Tumor-agnostic transcriptome-based  \nclassifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials  \nAndreas Roller  ,1 Iakov I Davydov  ,2 Petra C Schwalie  ,2  \nMartha L Serrano-Serrano,2 Astrid Heller,3 Nicolas Staedler,2 Cláudia S Ferreira,3 Gabriele Dietmann,3 Irina Klaman,3 Alberto Valdeolivas,2 Konstanty Korski,4 Michael A Cannarile3  \nTo cite: Roller A, Davydov II, Schwalie PC, et al. Tumoragnostic transcriptomebased classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials. Journal for ImmunoTherapy of Cancer 2024;12:e008185 . doi:10.1136/jitc-2023-008185  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2023-008185](jitc-2023-008185)) .  \nAR, IID and PCS are joint first authors.  \nAccepted 18 March 2024  \n© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Andreas Roller;  \n[andreas.roller@roche.com](andreas.roller@roche.com)[ ](andreas.roller@roche.com)Dr Iakov I Davydov;  \n[iakov.davydov@roche.com](iakov.davydov@roche.com)  \nABSTRACT  \nBackground The immune status of a patient’s tumor microenvironment (TME) may guide therapeutic interventions with cancer immunotherapy and help identify potential resistance mechanisms. Currently, patients’ immune status is mostly classified based on CD8+tumor-infiltrating lymphocytes. An unmet need exists for comparable and reliable precision immunophenotyping tools that would facilitate clinical treatment-relevant decision-making and the understanding of how to overcome resistance mechanisms.  \nMethods We systematically analyzed the CD8 immunophenotype of 2023 patients from 14 phase I–III clinical trials using immunohistochemistry (IHC) and additionally profiled gene expression by RNA-sequencing (RNA-seq) . CD8 immunophenotypes were classified by pathologists into CD8-desert, CD8-excluded or CD8-inflamed tumors using CD8 IHC staining in epithelial and stromal areas of the tumor. Using regularized logistic regression, we developed an RNA-seq-based classifieras a surrogate to the IHC-based spatial classification of CD8+tumor-infiltrating lymphocytes in the TME.  \nResults The CD8 immunophenotype and associated gene expression patterns varied across indications as well as across primary and metastatic lesions. Melanoma and kidney cancers were among the strongest inflamed indications, while CD8-desert phenotypes were most abundant in liver metastases across all tumor types. A good correspondence between the transcriptome and the IHC-based evaluation enabled us to develop a 92-gene classifier that accurately predicted the IHC-based CD8 immunophenotype in primary and metastatic samples (area under the curve inflamed=0 .846; excluded=0 .712; desert=0 .855) . The newly developed classifier was prognostic in The Cancer Genome Atlas (TCGA) data and predictive in lung cancer: patients with predicted CD8-inflamed tumors showed prolonged overall survival (OS) versus patients with CD8-desert tumors (HR 0 .88; 95% CI 0.80 to 0 .97) across TCGA, and longer OS on immune  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n\n| ⇒ T-cell infiltration, most commonly classified based on CD8+T cell immunohistochemistry (IHC) staining, and various tumor microenvironment (TME)-specific resistance mechanisms, can impact response rates to cancer immunotherapy.\u003Cbr>WHAT THIS STUDY ADDS |\n| --- |\n| ⇒ Our data provide new insights into the impact of tumor excision location and indication on the immune composition of the TME. We developed a transcriptome-based classifier tha","cbCaitUAri701crs","https://ap.wps.com/l/cbCaitUAri701crs","pdf",8281337,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What problem does the classifier address in cancer immunotherapy?\",\"answer\":\"It targets the need for reliable precision immunophenotyping of the tumor microenvironment beyond current CD8+ tumor-infiltrating lymphocyte classification to better guide therapeutic decisions and resistance understanding.\"},{\"question\":\"How were CD8 immunophenotypes determined in the study?\",\"answer\":\"CD8 immunophenotypes were classified by pathologists using CD8 immunohistochemistry staining in epithelial and stromal tumor areas, and gene expression was profiled by RNA sequencing.\"},{\"question\":\"What performance and clinical implications are reported for the 92-gene classifier?\",\"answer\":\"The classifier accurately predicted IHC-based CD8 immunophenotypes in primary and metastatic samples, and it showed prognostic and predictive value in independent patient data, including prolonged overall survival for predicted CD8-inflamed tumors.\"}]","Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials | PDF",1790020183,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fd6e6a55ea70186bc03bf03fe1c36d1.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/438db209ea150d8f1cb37643ad3d8512.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afc9372abfdd47249be6cc3e94a0d177.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43d12e4aacc5e229c75ff9c07ec79b61.webp",980,1306]